MIRA Pharmaceuticals, Inc. Share Price
MIRAMIRA Pharmaceuticals, Inc. Stock Performance
Open $1.32 | Prev. Close $1.29 | Circuit Range N/A |
Day Range $1.29 - $1.32 | Year Range $0.73 - $2.44 | Volume 300 |
Average Traded $1.30 |
MIRA Pharmaceuticals, Inc. Share Price Chart
About MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
MIRA Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
27-Feb-26 | $1.32 | $1.27 | -4.15% |
26-Feb-26 | $1.24 | $1.32 | +6.00% |
24-Feb-26 | $1.25 | $1.25 | +2.88% |
23-Feb-26 | $1.19 | $1.22 | +2.97% |
20-Feb-26 | $1.19 | $1.18 | -2.48% |
19-Feb-26 | $1.23 | $1.21 | -2.02% |
18-Feb-26 | $1.26 | $1.24 | -0.40% |